Today we have two short monologues for you on recent papers. The first, by popular request, is the problems with the VISION trial, which treated metastatic castration-resistant prostate cancer with lutetium-177–PSMA-617 (Lu-177–PSMA-617) radioligand therapy and standard of care. The second is on the paper recently published in Science titled "Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients".
Fecal transplant: doi.org/10.1126/science.abb5920
Back us on Patreon! www.patreon.com/plenarysession
Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
Fler avsnitt av Plenary Session
Visa alla avsnitt av Plenary SessionPlenary Session med Vinay Prasad, MD MPH finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
